Register now or log in to join your professional community.
before initiating and while on statin therapy, LFTs and lipid panels must be monitored - at baseline and every 6 to 12 months
moreover if patients are experiencing Side Effects such as muscle aches or rhabdomyalisis CPK can be measured to asses severity and wether patient is a candidate to switch to another statin or not
To decreases the cholesterol level in blood but it has side effects of Headache, Constipation and stomach ache. I would reccomend Rosuvastatin as it is more efficient
Evaluate serum cholesterol and triglyceride levels before initiation and monitor liver function tests prior to initiation of therapy and as clinically indicated
TO MONITOR CHOLESTROL LEVELS RELEASING BY LIVER LOW DENSITY CHOLESTROL SHOULD BE PERFECTLY DUE TO IMBALANCE IT LEEDS TO CARDIAC ARRRESTS
Inorder to measure the during and after
initially test is to make a baseline for the upcoming tests and to prescribe drug if patient need, where the periodically tests done to assess the effectiveness of the dose and drug
LFT ,before blood test for ensure liver in good condition and during blood test chec king health of liver
